Better Quantum Computing Stock for 2026: IonQ or Rigetti Computing?

IonQ has a technical edge with reported 99.99% two‑qubit gate fidelity and was selected for DARPA's Stage B Quantum Benchmarking Initiative, while Rigetti was not selected — a near‑term competitive setback for RGTI. Both names have seen large drawdowns from October highs (IonQ ~43%, Rigetti ~60%), and the article warns that commercial quantum utility remains years away (target windows cited toward 2030–2033), leaving share performance heavily dependent on shifts in market risk appetite rather than immediate revenue drivers.

Analysis

Market structure: DARPA Stage-B inclusion materially re-rates perceived viability — IonQ (IONQ) gains credibility, Rigetti (RGTI) loses procurement optionality and bargaining power. Hyperscalers (MSFT, GOOG) remain ultimate buyers/partners and retain pricing power; commercial demand is tiny today (research/defense) so near-term revenue share shifts are binary and contract-driven.

Risk assessment: Key tail risks are (1) a superconducting breakthrough or AI-classical algorithm reducing quantum premium, (2) export/regulatory limits on defense work, and (3) capital/dilution risk for pure-plays; expect market moves in days-weeks around DARPA/contract/news and fundamental business inflection not before 2030–2033. Hidden dependency: surviving vendors need cloud partnerships and >12–24 months of cash runway.

Trade implications: Favor small, asymmetric long exposure to IONQ and short exposure to RGTI via options to limit capital at risk; hedge market beta by pairing longs in IONQ with shorts in RGTI and adding 3–5% allocation to MSFT/GOOG as defensive optionality. Volatility trades: buy 9–15 month IONQ calls for convex upside; buy 3–6 month RGTI puts to express downside risk from funding stress.

Contrarian angles: Consensus underweights the value of sustained fidelity (IONQ’s 99.99% two‑qubit gate fidelity) as a durable moat vs speed; the market may be over-penalizing RGTI for a single DARPA omission — a recapitalization or Stage‑B addition would trigger sharp reversals. A surprise M&A by a hyperscaler would create a rapid takeover upside for winners.

Key Decisions for Investors

• Establish a 1.5–2.5% portfolio long in IONQ (IONQ) now as a high-risk, long‑dated optionality play; set tactical stop-loss at -30% and trim to half if no meaningful DARPA/contract news within 6 months. Consider replacing up to 50% of the equity leg with 12‑month ATM calls (max 0.5% of portfolio in premium) to cap downside.
• Establish a 0.5–1.0% short exposure to Rigetti (RGTI) via 3–6 month puts (or a small outright short) to express funding/credibility risk; cover immediately if RGTI is added to DARPA Stage B or completes a >$100M financing, or if stock rallies >40% from entry.
• Implement a pair trade: long IONQ sized 2x short RGTI (e.g., +2% IONQ / -1% RGTI) to reduce market beta and capture tech-lead differential; rebalance monthly and close the pair if DARPA revises Stage-B list within 90 days.
• Rotate 3–5% of portfolio from small-cap quantum names into MSFT (2–3%) and GOOGL (1–2%) as defensive exposure to quantum optionality and to hedge a sector‑wide risk-off; increase if implied volatility across small-cap quantum stocks rises >40%.